Balaxi Pharmaceuticals

Revenue growth of 40.3% on YoY basis, with operating EBITDA of Rs. 15.29 crore PAT stood at Rs. 8.23 crore Revenue from Pharmaceutical business grew by 40.4%…

Revenue up 23%, Profit After Tax expands 29% Pharma revenue up 50% with expanding contribution from Latin America Balaxi Pharmaceuticals Limited (Balaxi), a branded IPR-based pharmaceutical…